Meridian Bioscience Europe
Meridian Life Science
Get to Know Us
Market Focus
Board of Directors and Management
Meridian Bioscience Subsidiaries
Meridian Milestones
News
Contact Us
Calendar of Events
Webinars
Media
Meet the People
Life at Meridian
Mission and Core Values
Employee Benefits
Open Positions
Community Involvement
Investor Overview
Stock Information
Governance
News Releases
Fundamentals
Analyst Coverage
Annual Reports
Annual Meetings
SEC Filings
Investment Plan
Events and Presentations
Meridian Home
Investor Overview
Stock Information
Stock Quote
Stock Chart
Price Lookup
Calculator
Governance
Board of Directors
Management
Committee Composition
Committee Charters
Governance Documents
News Releases
Fundamentals
Snapshot
Trading Statistics
Balance Sheet
Income Statement
Cash Flow
Ratios
Analyst Coverage
Annual Reports
Annual Meeting
SEC Filings
All Filings
Annual Filings
Quarterly Filings
Proxy
Insider (Section 16)
Investment Plan
Events & Presentations
Request Info
Ask for our annual reports or more information
Email Alerts
Sign up for email alerts
Home
>
Investor Relations
> Definition
Share
Print
Investor Relations
Definition
Unusual Expense (Income)
Unusual Expense (Income) represents the sum of:
Purchased R&D Written-Off
Restructuring Charge
Litigation
Impairment – Assets Held for Use
Impairment – Assets Held for Sale
Other Unusual Expense (Income).
Copyright © 2019 Meridian Bioscience, Inc.
Home
About Meridian
Careers
Investors
Diagnostic Products
Disease Information
Technical Support
Customer Service
Tools & Resources
Contact Us
Privacy Policy
Meridian Bioscience Europe
Meridian Life Science